Inicio › Cáncer de endometrio › Pensilvania › Pittsburgh
Ensayos clínicos de Cáncer de endometrio en Pittsburgh, PA
23 estudios para Cáncer de endometrio buscan participantes en centros de Pittsburgh y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
ReclutandoFase 3
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- UPMC Cancer Center-Washington, Washington · A 23 mi de distancia
- y 1 más
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
ReclutandoFase 2
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC Hillman Cancer Center, Pittsburgh
- UPMC-Passavant Hospital, Pittsburgh
- y 3 más
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ReclutandoFase 1/2
- University of Pittsburgh Medical Center, Pittsburgh
A Phase 1 Study of the Safety and Tolerability of CTX-10726
ReclutandoFase 1
- UPMC Hillman Cancer Center, Pittsburgh
Distance-Based Exercise to Preserve Function and Prevent Disability
Reclutando
- UPMC Hillman Cancer Center, Pittsburgh
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
ReclutandoFase 2
- UPMC-Magee Womens Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- UPMC-Mercy Hospital, Pittsburgh
- y 12 más
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
ReclutandoFase 1
- Research Site, Pittsburgh
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
ReclutandoFase 1
- University of Pittsburgh Medical Center, Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- Allegheny Health Network, Pittsburgh
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
ReclutandoFase 3
- AHN West Penn Hospital ( Site 6006), Pittsburgh
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
ReclutandoFase 1/2
- Research Site, Pittsburgh
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
ReclutandoFase 3
- Research Site, Pittsburgh
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
ReclutandoFase 1
- UPMC Hillman Cancer Center, Pittsburgh
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
ReclutandoFase 1/2
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
ReclutandoFase 2
- West Penn Hospital, Pittsburgh
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
ReclutandoFase 1
- UPMC, Pittsburgh
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ReclutandoFase 1/2
- Allegheny Health Network, Pittsburgh
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
ReclutandoFase 3
- Research Site, Pittsburgh
- Research Site, Pittsburgh
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
ReclutandoFase 2
- 127, Pittsburgh
A Study of Lorigerlimab in Participants With Advanced Solid Tumors
ReclutandoFase 2
- West Penn Allegheny Health, Pittsburgh
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer
ReclutandoFase 2
- West Penn Hospital, Pittsburgh
A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer.
ReclutandoFase 2
- Allegheny Health, Pittsburgh
Ensayos de Cáncer de endometrio en otras ciudades
- Houston, TX68 estudios
- New York City, NY52 estudios
- Boston, MA50 estudios
- Arlington, VA39 estudios
- Nashville, TN38 estudios
- Los Angeles, CA34 estudios
- St. Louis, MO29 estudios
- Philadelphia, PA28 estudios
- San Antonio, TX27 estudios
- Columbus, OH25 estudios
- Chicago, IL25 estudios
- Oklahoma City, OK25 estudios
Otros estudios en Pittsburgh
- Cáncer de pulmón de células no pequeñas48 estudios
- Cáncer (todos los tipos)41 estudios
- Cáncer de seno39 estudios
- Cáncer del colon y del recto32 estudios
- Cáncer metastásico31 estudios
- Melanoma31 estudios
- Cáncer de ovario30 estudios
- Cáncer de próstata23 estudios
- Cáncer de pulmón23 estudios
- Carcinoma de células escamosas de cabeza y cuello22 estudios
- Accidente cerebrovascular22 estudios
- Depresión22 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.